Skip to content

Postoperative cognitive dysfunction in elderly cancer patients

Postoperative cognitive dysfunction in elderly cancer patients - POCD in elderly

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34981
Enrollment
150
Registered
2010-05-28
Start date
2010-08-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitive dysfunction memory and attention

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients over 65 years of age admitted to the Department of Surgery of the University Center Groningen for the surgical or combined cancer treatment (surgery / radiation /chemotherapy / hormonal therapy) of a solid tumor will be included in this study. This will include patients undergoing surgery for a malignancy of the breast, thyroid, soft tissue, hepatobilliairy tract, colorectal tumors, and skin tumors• surgery is scheduled more than 24 hours after inclusion in the study as we feel this is the time necessary to obtain test results and plan the intraoperative recording of data • surgery under general, local or regional anesthesia. • written informed consent given according to local regulations

Exclusion criteria

Exclusion criteria: • any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.;• patient unable to comply with the outcome questionnaires

Design outcomes

Primary

MeasureTime frame
The incidence of POCD defined by a postoperative change in cognitive function measured by the Ruff Figural Fluency (RFFT) score and Trailmaking test (TMT) score in comparison to the preoperatieve score. Secondary outcome measures are

Secondary

MeasureTime frame
memory (measured by the 15 words test) and daily functioning and quality of life measured by the instruments in the "minimale dataset (MDS)". These tests will be performed preoperatively and at discharge (or a maximum of 2 weeks postoperatively) and 3 months postoperatively.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)